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Abstract
The mesomeric betaine imidazolium-1-ylphenolate forms a borane adduct with tris(pentafluorophenyl)borane by coordination with
the phenolate oxygen, whereas its NHC tautomer 1-(2-phenol)imidazol-2-ylidene reacts with (triphenylphosphine)gold(I) chloride
to give the cationic NHC complex [Au(NHC)2][Cl] by coordination with the carbene carbon atom. The anionic N-heterocyclic
carbene 1-(2-phenolate)imidazol-2-ylidene gives the complexes [K][Au(NHC−)2], [Rh(NHC−)3] and [Ni(NHC−)2], respectively.
Results of four single crystal analyses are presented.
Introduction
Since the first isolation of a stable N-heterocyclic carbene
(NHC) [1] in 1991 this compound class has provided numerous
highly efficient ligands of NHC-metal catalysts for cross-cou-
pling reactions [2-7], versatile organocatalysts [8-10], and
starting materials for heterocycle syntheses [11-13]. Conse-
quently books [14-16] and reviews cover the range from NHC
structures in the light of their early history [17], syntheses
[6,18], coordination chemistry [19,20], and catalysis [21,22], to
biological activities of NHC complexes [23,24]. In the last
decade, attention has also been directed to anionic N-hetero-
cyclic carbenes [25]. In this context, mesomeric betaines are
interesting from two viewpoints. They are not only able to
undergo tautomerisations to neutral NHCs and thus provide a
safe storage form of otherwise unstable species [26,27], but
proved also to be suitable starting materials for the generation
of anionic NHCs by deprotonation. As examples of the latter
mentioned species, sydnone anions 1 [28], imidazole-2-ylidene-
4-olate 2 [29] as well as its 4-aminide derivatives [30] have
been prepared from mesoionic compounds (Figure 1). The
carbenes 3 [31] and 4 [32,33] originate from a conjugated ylide
and a cross-conjugated mesomeric betaine, respectively. A
review elucidates the interconversions of mesomeric betaines to
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Figure 1: Examples of anionic N-heterocyclic carbenes.
Scheme 1: A postulated mesomeric betaine – NHC equilibrium (6A/6B) and formation of an anionic NHC 7. Formation of borane adduct 8 of
tautomer 6A, a cationic gold complex 9 of tautomer 6B, and an anionic gold complex 10 of anionic NHC 7. a) K2CO3, MeOH, reflux, 4 h, 98%.
b) LiN(TMS)2, pyridine, rt, 100%. c) B(C6F5)3, dioxane, reflux, 43%. d) (PPh3)AuCl, THF, reflux, 60%; X = Cl/Br. e) K2CO3, MeOH, 100%.
different types of N-heterocyclic carbenes (NHC, aNHC, rNHC,
MICs) and vice versa [34].
Herein, conjugated mesomeric betaine 2-(1-butyl-1H-imida-
zolium-3-yl)phenolate, its tautomeric NHC and its anionic NHC
are shown to serve as monodentate and bidentate ligands, re-
spectively.
Results and Discussion
Salt 5 is available via a three-step procedure [35]. Deproton-
ation with potassium carbonate resulted in the formation of the
tautomeric equilibrium of the mesomeric betaine 6A and its
NHC 6B (Scheme 1). The NMR spectra measured in a variety
of solvents (DMSO-d6, MeCN-d3, MeOD-d4, D2O, THF-d8)
show that the polar mesomeric betaine 6A is the only detectable
tautomer under these conditions; unfortunately the addition of
less polar solvents induces a precipitation from solution so that
detection of the NHC tautomer by NMR spectroscopy is not
possible under these conditions. Base screening revealed that
the anionic N-heterocyclic carbene 7 can be generated in
quantitative yield at rt with lithium bis(trimethylsilyl)amide in
THF/pyridine due to its superior solubility. As evidenced by
1H NMR and 13C NMR spectroscopy, the carbene 7 proved to
be stable in pyridine-d5 solution up to 50 °C. The resonance
frequency of the carbene carbon atom can be detected at
δ = 203 ppm. Minute traces of water protonate the anionic NHC
7 spontaneously to give 6A/B without any traces of decomposi-
tion products.
The betaine 6A reacted with tris(pentafluorophenyl)borane in
dioxane at reflux temperature to give the borane adduct 8. The
proton attached to C-2 of the imidazolium ring (crystallo-
graphic numbering, cf. Figure 2: C9) is clearly detectable at
δ = 9.22 ppm in DMSO-d6, while the boron and fluorine atoms
give resonance frequencies at δ = −3.45 ppm, and δ = −133.91,
−159.97, −165.18 ppm in the 11B NMR and 19F NMR spectra,
respectively. A single crystal X-ray analysis of the borane
adduct displays two different conformers in the unit cell
Beilstein J. Org. Chem. 2016, 12, 2673–2681.
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Figure 2: Molecular drawing of one of the two crystallographic inde-
pendent molecules of borane adduct 8 (displacement parameters are
drawn at 50% probability level; crystallographic numbering).
which differ inter alia in the torsion angles around the
Nimidazole–Cphenol bonds [−53.32(16)° vs 114.12(13)°] and the
Cphenyl–O bonds [49.43(17)° vs −15.29(18)°] (Figure 2).
A gold complex of the N-heterocyclic carbene tautomer 6B can
be obtained on reaction with (triphenylphosphine)gold(I)
chloride in boiling anhydrous THF under a nitrogen atmo-
sphere, under which conditions the colorless gold complex
[Au(6B)2][Cl] (9) is formed in 60% yield (Scheme 1). The
protons of the OH resonate at δ = 10.34 ppm in DMSO-d6, and
the 13C NMR chemical shift of the carbene atom appears at
δ = 183.9 ppm. Single crystals of the gold complex 9 were ob-
tained by slow evaporation of a concentrated solution of 9 in
MeOH and a molecular drawing is shown in Figure 3. The
X-ray structure revealed a mixed occupation of the same posi-
tion with chloride and bromide anions (4:1). The bond length
between the gold atom and the carbene carbon atom (crystallo-
graphic numbering: Au1–C2) was found to be 202.11(15) pm
and this value corresponds to the distances in other NHC gold
complexes [36,37].
The coordination about the Au(I) center is almost linear, as a
C2–Au(1)–C2A bond angle of 177.35(8)° was found. However,
in contrast to other gold complexes, the two imidazole rings are
not coplanar [38]. In addition, the imidazole and the phenol
rings are twisted about −119.84(16)° (C5–N1–C6–C7) relative
to the imidazole ring. Two Au complexes are connected via one
halide anion which is involved in hydrogen bonds between two
OH groups. On treatment with methanolic potassium carbonate,
the two OH groups of gold complex 9 can be deprotonated to
Figure 3: Molecular drawing of the cation of the gold complex 9 (dis-
placement parameters are drawn at 50% probability level; crystallo-
graphic numbering).
give the anionic complex [K][Au(7)2] 10 of the anionic
N-heterocyclic carbene 7 in quantitative yield (Scheme 1). ESI
mass spectra taken in the anion detection mode show the peak
of 10 as base peak at m/z = 627.
The anionic N-heterocyclic carbene 7 also forms a rhodium and
a nickel complex (Scheme 2). The colorless rhodium complex
[Rh(7)3] 11 was prepared on reaction of the tautomeric mixture
6A/B with either chlorido(1,5-cyclooctadiene)rhodium(I) dimer,
or with bis(triphenylphosphine)rhodium(I) carbonyl chloride in
anhydrous toluene at reflux temperature, respectively. During
these reactions, the water of crystallization of the starting mate-
rial is – at least partially – removed by azeotropic distillation
and Rh(I) is obviously oxidized to Rh(III). In order to balance
the chemical equation, the formation of elemental hydrogen and
of one equivalent of HCl can be postulated. Neither hydrogen
nor reduced species such as cyclooctane or cyclooctene, howev-
er, have been detected. In the ESI mass spectra the base peak
was detected at m/z = 749.2 which corresponds to the molecu-
lar peak of a [Rh(7)3 + H]+ complex. In the 13C NMR spectra,
the Ccarbene resonance frequencies were detected at 173.5 ppm,
171.0 ppm, and 164.4 ppm and have been identified by their
1JRhCcarbene couplings of 35.6 Hz, 35.6 Hz, and 48.5 Hz, re-
spectively. These chemical shifts are in a more upfield region
and the coupling constants are smaller than in other complexes
such as the neutral N-heterocyclic oxocarbene (NHOC)
rhodium complex ([Rh(NHOC)Cl(COD)] of 2 (R = Mes;
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δCcarbene = 229.7 ppm; 1JRhCcarbene = 51.5 Hz) as well as its
enol ethers (δCcarbene = 171–177 ppm) [29,39], and other Rh
complexes [40,41]. Correspondingly the phenol proton signals
of the three geometrically non-equivalent ligands appear at dif-
ferent resonance frequencies. Thus, the three unsubstituted
ortho positions of the phenolate moieties are detectable at
6.93–6.97 ppm (overlapped), 6.72 ppm, and 5.81 ppm, respec-
tively.
Scheme 2: The anionic NHC 7 forms a rhodium complex and a nickel
complex. d) [RhCl(COD)]2, toluene, rt to reflux (50%).
e) [RhCl(PPh3)2(CO)], toluene, reflux, 57%. f) NiCl2(PPh3)2, THF, rt to
reflux, 45%.
Single crystals of [Rh(7)3] (11) were obtained by slow evapora-
tion of a concentrated solution of 11 in a mixture of EtOAc and
MeOH. The single crystal X-ray analysis proved that three an-
ionic N-heterocyclic carbenes 7 serve as bidentate ligands, re-
spectively (Figure 4). The n-butyl group connected to N25 is
disordered. The bond lengths between the rhodium atom and the
carbene atoms (C1, C21 and C41) were determined to be
196.6(2), 204.7(2) and 204.4(2) pm. In the literature-known
complexes [Rh(ICy3)(CO)][PF6], [Rh(IiPr2Me2)3(CO)][PF6],
and [Rh(ICy)(IiPr2Me2)2(CO)][PF6] bond lengths between
206.38(11) and 214.90(13) pm were found [40], whereas the
two independent molecules of [Rh(IBioxMe4)3][BArF4] in the
elemental cell have one Rh–Ccarbene bond of 194.1(2) pm and
193.4(2) pm, respectively, trans to a free coordination site of
this naked low-coordinate rhodium complex [41]. Correspond-
ingly the Rh–O15 (202.49(14) pm) and Rh–O35 bond lengths
cis to the shortened Rh–Ccarbene bond in 11 are identical
(2.0244(14) pm), whereas the Rh–O55 bond trans to this bond
is longer (209.98(15) pm). The phenolate rings are twisted in
relation to the imidazole rings and the determined dihedral
angles for C1–N2–C10–C15, C21–N22–C30–C35, and
C41–N42–C50–C55 are 26.371(5)°, 18.939(5)°, and
Figure 4: Molecular drawing of rhodium complex 11 (minor disorder
parts omitted for clarity, displacement parameters are drawn at 50%
probability level; crystallographic numberings).
−33.008(5)°, respectively. The carbenes are twisted by approxi-
mately 28.1° to 37.0° in relation to the Rh–Ccarbene bonds.
The reaction of 6A/6B with bis(triphenylphosphine)nickel(II)
chloride at reflux temperature resulted in the formation of the
nickel complex [Ni(7)2] (12, Scheme 2). Single crystals were
obtained by slow evaporation of 12 from EtOAc/MeOH. The
X-ray analysis shows two independent nickel complexes which
are connected via hydrogen bonds to two water molecules
(Figure 5). The nickel atom is in the center of an essentially
square planar environment, as the sums of the bond angles are
363.81° and 364.76°, respectively. The ligand adopts a cis
arrangement around the Ni atom. The Ni–O bond lengths were
determined to be 187.60(13) pm and 190.11(13) pm, whereas
the Ni–Ccarbene bonds have lengths between 184.06(19) pm and
184.82(19) pm, respectively. These values correspond to litera-
ture-known bond lengths of cis arranged bidentate ligands
around Ni [42-44], but, as expected, they differ from those of
[(PEt3)(Ph)Ni(imidazo[1,5-a]quinolin-9-olate-1-ylidene)] [45]
as well as Ni complexes with tridentate ligands [46,47].
Conclusion
In summary, this publication presents four molecules which
differ only in their number and positions of protons. Starting
from cation 5, the neutral compound 6A (betaine) was formed
and detected spectroscopically, whereas its tautomeric carbene
6B could not be characterized in non-complexed form. Depro-
tonation of 6A/B gave the anionic NHC 7. The two tautomers
Beilstein J. Org. Chem. 2016, 12, 2673–2681.
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Figure 5: Molecular drawing of the dimeric nickel complex 12 (displacement parameters are drawn at 50% probability level; crystallographic number-
ings).
6A/6B and the anionic NHC 7 could be trapped as complexes.
These results supplement our knowledge about the interesting
area of overlap between mesomeric betaines and N-hetero-
cyclic carbenes [34] and of structurally related zwitterionic
motifs known in the literature [48-52].
Experimental
General considerations. Silica gel 60 (0.040–0.063 mm) was
used for flash-chromatographic separations. The NMR spectra
were obtained with a Bruker Avance 400 and Bruker Avance III
600 MHz spectrometer, and 1H NMR spectra were recorded at
400 MHz or 600 MHz. 13C NMR spectra were recorded at 100
MHz or 150 MHz. The solvent peak or tetramethylsilane was
used as the internal reference. The multiplicities are described
here by using the following abbreviations: s = singlet, d =
doublet, t = triplet, q = quartet, and m = multiplet, and the signal
orientations in DEPT experiments were described as follows:
o = no signal; + = up (CH, CH3); − = down (CH2). For NMR
peak assignments we numbered the compounds not necessarily
in accordance with IUPAC rules to allow comparisons. Thus,
“C-2” always refers to C-2 of the imidazolium and imidazol-2-
ylidene ring, respectively. The spectroscopic numbering, which
differ from the crystallographic numbering, is presented on the
NMR spectra in Supporting Information File 1. All FTIR spec-
tra were measured with a Bruker Alpha T spectrometer in the
range of 400 to 4000 cm−1. The mass spectra were obtained
with a Varian 320 MS Triple Quad GC/MS/MS instrument with
a Varian 450-GC. All electrospray ionisation mass spectra
(ESIMS) were measured with a Hewlett-Packard/Agilent
LCMSD series HP 1100 spectrometer with APIES. The com-
pound samples were sprayed from MeOH at 4000 V capillary
voltage and fragmentor voltages of 30 V, unless otherwise
noted. Melting points are uncorrected and were determined in
an apparatus according to Dr. Tottoli (Büchi). All HRMS spec-
tra were obtained with a Bruker Daltonik Tesla-Fourier trans-
form–ion cyclotron resonance mass spectrometer with electro-
spray ionisation.
The single-crystal X-ray diffraction studies were carried out on
a Bruker D8 Venture diffractometer with Photon100 detector at
123(2) K using Cu Kα (8) and Mo Kα radiation (9, 11, 12)
(λ = 1.54178 Å and 0.71073 Å). Dual space methods (8,
SHELXT) [53] and direct methods (9, 11, 12, SHELXS-97)
[54] were used for structure solution and refinement was carried
out using SHELXL-2014 (full-matrix least-squares on F2).
Hydrogen atoms were localized by difference electron density
determination and refined using a riding model (H(O) free).
Semi-empirical absorption corrections were applied. For 8, 9,
and 11 an extinction correction was applied. In 9 the halogen
counter anion (occupancy Cl/Br approx. 81:19) and in 11 one
n-butyl group are disordered.
8: colorless crystals, C31H16BF15N2O, Mr = 728.27, crystal size
0.35 × 0.25 × 0.15 mm, monoclinic, space group P21/n (No.
14), a = 21.9006(7) Å, b = 13.1620(4) Å, c = 22.0149(7) Å, β =
117.982(1)°, V = 5650.1(3) Å3, Z = 8, ρ = 1.712 Mg/m−3, µ(Cu
Kα) = 1.552 mm−1, F(000) = 2912, 2Θmax = 144.4°, 56172
reflections, of which 11099 were independent (Rint = 0.024),
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902 parameters, R1 = 0.030 (for 10343 I > 2σ(I)), wR2 = 0.074
(all data), S = 1.04, largest diff. peak/hole = 0.359/−0.191 e
Å−3. There are 2 different conformers in the asymmetric unit.
9: colorless crystals, C26H32AuN4O2∙0.19(Br)∙0.81(Cl), Mr =
673.42, crystal size 0.24 × 0.12 × 0.06 mm, monoclinic, space
group C2/c (No. 15), a = 15.0275(9) Å, b = 13.1392(7) Å, c =
13.0205(7) Å, β = 104.161(2)°, V = 2492.8(2) Å3, Z = 4, ρ =
1.794 Mg/m−3, µ(Mo Kα) = 6.324 mm−1, F(000) = 1326,
2Θmax = 55.2°, 46420 reflections, of which 2867 were indepen-
dent (Rint = 0.026), 162 parameters, R1 = 0.011 (for 2788 I >
2σ(I)), wR2 = 0.026 (all data), S = 1.10, largest diff. peak/hole =
0.404/−0.489 e Å−3, disorder of the halogen counter anion
(occupancy Cl/Br 0.813(2):0.187(2)).
11: yellow crystals, C39H45N6O3Rh, Mr = 748.72, crystal size
0.38 × 0.32 × 0.16 mm, monoclinic, space group P21/n (No.
14), a = 11.7692(5) Å, b = 18.8111(7) Å, c = 16.2459(7) Å, β =
104.615(2)°, V = 3480.3(2) Å3, Z = 4, ρ = 1.429 Mg/m−3, µ(Mo
Kα) = 0.538 mm−1, F(000) = 1560, 2Θmax = 55.2°, 90530
reflections, of which 8005 were independent (Rint = 0.046), 436
parameters, 146 restraints, R1 = 0.032 (for 6902 I > 2σ(I)), wR2
= 0.071 (all data), S = 1.05, largest diff. peak/hole =
0.645/−0.996 e Å−3, disorder of the n-butyl group.
12: yellow crystals, C26H30N4NiO2∙H2O, Mr = 507.26, crystal
size 0.22 × 0.12 × 0.04 mm, monoclinic, space group P21/n
(No. 14), a = 11.2267(5) Å, b = 22.8310(9) Å, c = 19.1274(8)
Å, β = 100.099(2)°, V = 4826.7(4) Å3, Z = 8, ρ = 1.396 Mg/
m−3, µ(Mo Kα) = 0.839 mm−1, F(000) = 2144, 2Θmax = 55.2°,
89393 reflections, of which 11117 were independent (Rint =
0.070), 625 parameters, 6 restraints, R1 = 0.038 (for 8729 I >
2σ(I)), wR2 = 0.095 (all data), S = 1.06, largest diff. peak/hole =
1.063/−0.370 e Å−3, dimer.
CCDC 1489189 (8), 1489190 (9), 1489191 (11), and 1489192
(12) contain the supplementary crystallographic data for this
paper. These data can be obtained free of charge from The
Cambridge Crystallographic Data Centre via http://
www.ccdc.cam.ac.uk/data_request/cif.
Preparation of lithium 2-(3-butyl-1H-imidazol-2-ylidene-1-
yl)phenolate (7): A solution of 0.02 g (0.09 mmol) of 2-(3-
butyl-1H-imidazolium-1-yl)phenolate [35] and 0.10 mL of lithi-
um bis(trimethylsilyl)amide (1.0 M solution in THF) in 0.7 mL
of pyridine was stirred for 30 minutes at rt. The product was
characterized in solution, as traces of moisture reconstituted the
starting material. Concentration of the solution in vacuo, filtra-
tion and crystallization of the mother liquor in the presence of
one drop of water gave 6A/B in quantitative yield. Yield of 7:
0.02 g (100%). 1H NMR (600 MHz, pyridine-d5) δ 7.44 (d, J =
0.8 Hz, 1H, H-5), 7.40 (dd, J1 = 1.0 Hz, J2 = 7.6 Hz, 1H, H-11),
7.16–7.12 (m, 2H, H-9/8), 7.05 (d, J = 0.8 Hz, 1H, H-4), 6.59
(ddd, J1 = 0.9 Hz, J2 = 7.3 Hz, J3 = 7.6 Hz, 1H, H-10), 3.94 (t, J
= 7.0 Hz, 2H, H-12), 1.68–1.62 (m, 2H, H-13), 1.19–1.15 (m,
2H, H-14), 0.75 (t, J = 7.3 Hz, 3H, H-15) ppm; 13C NMR (150
MHz, pyridine-d5) δ 203.1 (o, C-2), 162.2 (o, C-7), 131.0 (o,
C-6), 127.2 (+, C-9), 123.0 (+, C-8), 122.7 (+, C-11), 119.5 (+,
C-5), 118.5 (+, C-4), 111. 2 (+, C-10), 50.7 (−, C-12), 33.5 (−,
C-13), 19.8 (−, C-14), 13.5 (+, C-15) ppm; ESIMS (50 V) m/z
(%): 215.1 (100) [M − Li]−.
Preparation of (2-(3-butyl-1H-imidazolium-1-yl)phenoxy)-
tris(perfluorophenyl)borate (8): Under an inert atmosphere a
solution of 0.108 g (0.50 mmol) of 2-(3-butyl-1H-imidazolium-
1-yl)phenolate and 0.152 mg (1.0 mmol) of tris(pentafluoro-
phenyl)borane in 10 mL of dry dioxane was stirred at reflux for
4 h in a bomb tube. Then, the solvent was distilled off in vacuo.
The product was separated by column chromatography (silica
gel, EtOAc). Yield: 0.155 g (43%) of a colorless solid, mp
230 °C; 1H NMR (600 MHz, DMSO-d6) δ 9.22 (dd, J1 = 1.4
Hz, J2 = 1.5 Hz, 1H, H-2), 7.90 (dd, J1 = 1.4 Hz, J2 = 1.5 Hz,
1H, H-4), 7.82 (dd, J1 = 1.4 Hz, J2 = 1.5 Hz, 1H, H-5), 7.43
(dd, J1 = 2.3 Hz, J2 = 9.8 Hz, 1H, H-11), 7.17 (ddd, J1 = 2.3 Hz,
J2 = 7.4 Hz, J3 = 8.4 Hz, 1H, H-9), 6.81 (ddd, J1 = 1.0 Hz, J2 =
7.4 Hz, J3 = 9.8 Hz, 1H, H-10), 6.60 (dd, J1 = 1.0 Hz, J2 = 8.4
Hz, 1H, H-8), 4.18 (t, J = 10.8 Hz, 2H, H-12), 1.72–1.64 (over-
lapped, 2H, H-13), 1.22–1.13 (overlapped, 2H, H-14), 0.84 (t, J
= 11.0 Hz, 3H, H-15) ppm; 13C NMR (150 MHz, DMSO-d6) δ
152.5 (o, C-7), 147.2 (o, d, 1JC,F = 242.1 Hz, C-20), 138.2 (o, d,
1JC,F = 230.3 Hz, C-21), 136.3 (+, C-2), 135.8 (o, d, 1JC,F =
235.5 Hz, C-19), 130.2 (+, C-9), 125.4 (o, C-6), 125.0 (+,
C-11), 123.5 (+, C-5), 121.8 (o, C-4), 122.2–121.3 (+/o, C-18),
117.7 (+, C-10), 117.4 (+, C-8), 48.7 (−,C-12), 31.4 (−, C-13),
18.6 (−, C-14), 13.0 (+, C-15) ppm; 11B NMR (DMSO-d6, 128
MHz, external reference) δ −3.45 ppm; 19F NMR (DMSO-d6,
565 MHz, Cl3CF) δ −133.91 (d, 3JF,F = 21.5 Hz, 6F, F-19/19'),
−159.97 (t, 3JF,F = 21.5 Hz, 3F, F-21), −165.18 (dd, 3JF,F = 21.5
Hz, 6F, F-20/20', partially overlapped) ppm; IR (ATR) : 1511,
1498, 1456, 1304, 1277, 1262, 1079, 1038, 974, 965, 945, 936,
802, 768, 762, 755, 733, 691, 673, 667, 654, 649 cm−1; ESIMS
(50 V) m/z (%): 727.0 (100) [M − H]−. HRESIMS: calcd for
C31H15N2OF15B−, 727.1038; found, 727.1038.
Preparation of bis(3-butyl-1-(2-hydroxyphenyl)-1H-imida-
zolium-2-yl)gold monochloride (9): A solution of 0.43 g
(0.20 mmol) of 2-(3-butyl-1H-imidazolium-1-yl)phenolate in
5 mL of anhydrous THF was treated with 0.05 g (0.10 mmol) of
(triphenylphosphine)gold(I) chloride and stirred under an inert
atmosphere overnight at reflux temperature. The resulting solid
was filtered off, washed with THF, and dried in vacuo. Yield:
0.40 g (60%) of a yellow solid, mp 242 °C; 1H NMR
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(600 MHz, CD3OD) δ 7.39 (d, J = 2.0 Hz, 2H, H-4/4'), 7.37
(dd, J1 = 1.6 Hz, J2 = 7.7 Hz, 2H, H-11/11'), 7.38–7.33 (over-
lapped signals, 4H, H-5/5'/9/9'), 7.01 (dd, J1 = 1.3 Hz, J2 = 8.2
Hz, 2H, H-8/8'), 6.93 (ddd, J1 = 1.3 Hz, J2 = 7.5 Hz, J3 = 7.7
Hz, 2H, H-10/10´), 4.01 (t, J = 7.1 Hz, 4H, H-12/12'), 1.71–1.66
(m, 4H, H-13/13'), 1.22–1.15 (m, 4H, H-14/14'), 0.88 (t, J = 7.3
Hz, 6H, H-15/15') ppm; 1H NMR (600 MHz, DMSO-d6) δ
10.34 (s broad, 2H, OH), 7.62 (d, J = 1.9 Hz, 2H, H-2/2'), 7.57
(d, J = 1.9 Hz, 2H, H-3/3'), 7.38 (dd, J1 = 1.7 Hz, J2 = 7.8 Hz,
2H, H-11/11'), 7.34 (ddd, J1 = 1.7 Hz, J2 = 7.6 Hz, J3 = 8.2 Hz,
2H, H-9/9'), 7.06 (dd, J1 = 1.3 Hz, J2 = 8.2 Hz, 2H, H-8/8'),
6.93 (ddd, J1 = 1.3 Hz, J2 = 7.6 Hz, J3 = 7.8 Hz, 2H, H-10/10'),
3.96 (t, J = 7.0 Hz, 4H, H-12/12'), 1.59–1.64 (m, 4H, H-13/13'),
1.05–1.11 (m, 4H, H-14/14'), 0.81 (t, J = 7.3 Hz, 6H, H-15/15')
ppm; 13C NMR (150 MHz, CD3OD) δ183.9 (o, C-2/2'), 152.5
(o, C-7/7'), 130.3 (+, C-9/9'), 128.1 (+, C-11/11'), 126.8 (o, C-6/
6'), 123.8 (+, C-5/5'), 120.7 (+, C-4/4'), 119.1 (+, C-10/10'),
116.5 (+, C-8/8'), 50.4 (−, C-12/12'), 32.9 (−, C-13/13'), 19.2 (−,
C-14/14'), 13.6 (+, C-15/15') ppm; IR (ATR) : 2956, 1598,
1509, 1463, 1455, 1285, 1241, 829, 766, 752, 734, 687 cm−1;
MS (ESI 5 V) m/z (%) = 629.1 (100) M+. HRESIMS: calcd for
C26H32N4O2Au+, 629.2192; found, 629.2191.
Preparation of potassium bis(3-butyl-1-(2-phenolate)-1H-
imidazolium-2-yl)gold (10): A solution of 0.066 g (0.10 mmol)
of bis(3-butyl-1-(2-hydroxyphenyl)-1H-imidazolium-2-yl)gold
chloride (9) and 0.014 g (0.10 mmol) of K2CO3 in 5 mL of
methanol was stirred for 30 minutes under ultrasound irradia-
tion. After concentrating the solution in vacuo, the resulting
colorless solid was filtered off. Yield: 0.066 g (100%), mp
240 °C; 1H NMR (600 MHz, CD3OD) δ 7.34 (d, J = 1.8 Hz,
2H, H-4/4'), 7.21–7.23 (overlapped signals, 4H, H-4/4' and
H-11/11'), 7.08 (ddd, J1 = 1.86 Hz, J2 = 7.3 Hz, J3 = 8.3 Hz,
2H, H-9/9'), 6.80 (dd, J1 = 1.2 Hz, J2 = 8.3 Hz, 2H, H-8/8'),
6.43 (ddd, J1 = 1.2 Hz, J2 = 7.3 Hz, J3 = 7.5 Hz, 2H, H-10/10'),
4.00 (t, J = 7.1 Hz, 4H, H-12/12'), 1.70–1.65 (m, 4H, H-13/13'),
1.26–1.19 (m, 4H, H-14/14'), 0.88 (t, J = 7.3 Hz, 6H, H15/15')
ppm; 13C NMR (150 MHz, CD3OD) δ 183.5 (o, C-2/2'), 162.5
(o, C-7), 160.1(o, C-7'), 129.5 (+, C-9/9'), 129.2 (o, C-6/6'),
127.4 (+, C-11/11'), 124.1 (+, C-5/5'), 121.2 (+, C-8/8'), 119.7
(+, C-4/4'), 111.9 (+, C-10/10'), 50.2 (−, C-12/12'), 33.1 (−,
C-13/13'), 19.3 (−, C-14/14'), 12.7 (+, C-15/15') ppm; IR (ATR)
: 3157, 2958, 1637, 1591, 1483, 1447, 1311, 1246, 1076,
1061, 844, 748, 701, 566 cm−1; ESIMS (50 V) m/z (%): 627.2
(100) [M − K]−.
Preparation of tris(3-butyl-1-(2-oxidophenyl)-1H-imida-
zolium-2-yl)rhodium (11): Method A: A solution of 0.16 g
(0.72 mmol) of 2-(3-butyl-1H-imidazolium-1-yl)phenolate in
5 mL of anhydrous toluene was treated with 0.06 g (0.12 mmol)
of chloro(1,5-cyclooctadiene)rhodium(I) dimer and stirred
under an inert atmosphere overnight at reflux temperature. The
resulting colorless solid was filtered off, washed with THF and
dried in vacuo. Yield: 0.09g (50%) of a yellow solid, mp:
280 °C. Method B: A solution of 0.16 g (0.72 mmol) of 2-(3-
butyl-1H-imidazolium-1-yl)phenolate in 5 mL of anhydrous tol-
uene was treated with 0.17 g (0.24 mmol) of bis(triphenylphos-
phine)rhodium(I) carbonyl chloride and stirred under an inert
atmosphere overnight at reflux temperature. The resulting color-
less solid was filtered off, washed with THF and dried in vacuo.
Yield: 0.10g (57%) of a yellow solid, mp 280 °C; 1H NMR
(600 MHz, CD3OD) δ 8.00 (d, J = 2.2 Hz, 1H, H-5), 7.82 (d, J
= 2.2 Hz, 1H, H-5'), 7.52 dd, J1 = 1.5 Hz, J2 = 8.2 Hz, 1H,
H-11), 7.44 (d, J = 2.2 Hz, 1H, H-4), 7.39 (d, J = 2.0 Hz, 1H,
H-4'), 7.29 (d, J = 2.2 Hz, 1H, H-5''), 7.12 (d, J = 2.0 Hz, 1H,
H-5'), 7.11 (dd, J1 = 1.5 Hz, J2 = 8.2 Hz, 1H, H-11'), 7.05 (dd,
J1 = 1.4 Hz, J2 = 8.1 Hz, 1H, H-11''), 6.97–6.93 (m, 2H, H-8/9),
6.80 (ddd, J1 = 1.5 Hz, J2 = 7.0 Hz, J3 = 8.2 Hz, 1H, H-9'), 6.72
(dd, J1 = 1.5 Hz, J2 = 8.3 Hz, 1H, H-8'), 6.64–6.60 (overlapped
signals, 2H, H-9''/10), 6.57 (ddd, J1 = 1.5 Hz, J2 = 7.0 Hz, J3 =
8.3 Hz, 1H, H-10'), 6.41 (ddd, J1 = 1.4 Hz, J2 = 7.3 Hz, J3 = 8.1
Hz, 1H , H-10''), 5.81 (dd, J1 = 1.3 Hz, J2 = 8.1 Hz, 1H, H-8''),
4.33 (ddd, J1 = 4.8 Hz, J2 = 11.8 Hz, J3 = 16.7 Hz, 1H, H-12),
4.49 (ddd, J1 = 4.8 Hz, J2 = 11.8 Hz, J3 = 16.7 Hz, 1H, H12),
3.78 (t, J = 8.5 Hz, 2H, H-12'), 3.78–3.64 (m, 2H, H-12''),
1.70–1.64 (m, 1H, H-13), 1.62–1.56 (m, 1H, H-13), 1.53–1.45
(m, 1H, H-13'), 1.37–1.30 (m, 1H, H-13'), 1.27–1.18 (m, 1H,
H-14), 1.08–0.89 (m, 8H, 13''/14/ 2 × H-14'/14''/15), 0.88–0.82
(m, 1H, H-14'), 0.79–0.72 (m, 1H, H-13''), 0.68 (t, J = 7.3 Hz,
3H, H-15'), 0.63 (t, J = 7.4 Hz, 3H, H-15'') ppm; 13C NMR (150
MHz, CD3OD) δ 173.5 (o, d, 1JC,Rh = 35.6 Hz, C-2), 171.0 (o,
d, 1JC,Rh = 35.6 Hz, C-2'), 164.4 (o, d, 1JC,Rh = 48.5 Hz, C-2''),
160.2 (o, C-7), 159.8(o, C-7'), 157.3 (o, C-7''), 130.5 (o, C-6),
129.8 (o, C-6'), 128.2 (o, C-6''), 126.6 (+, C-9), 126.1 (+, C-9'),
125.9 (+, C-9''), 123.4 (+, C-8), 122.9 (+, C-4), 122.7 (+, C-8'),
122.2 (+, C-4'), 121.3 (+, C-8''), 120.8 (+, C-4''), 120.7 (+,
C-11), 119.6 (+, C-11'), 118.7 (+, C-11''), 118.4 (+, C-5), 118.4
(+, C-5'), 117.8 (+, C-5''), 115.1 (+, C-10), 114.1 (+, C-10'),
113.6 (+, C-10''), 48.7/48.3/48.2 (−, C-12/12'/12''), 32.5/32.3/
32.0 (−, C-13/13'/13''), 20.0/19.7/19.7 (−, C-14/14'/14''), 12.9/
12.4/12.4 (+, C-15/15'/15'') ppm; IR (ATR) : 2955, 1590,
1419, 1374, 1302, 1268, 1122, 950, 850, 742, 716, 698, 690,
683, 657 cm−1; ESIMS (30 V) m/z (%): 749.2 (100) [M+H]+;
HRESIMS: calcd for C39H46N6O3Rh+, 749.2686; found,
749.2685.
Preparation of bis(3-butyl-1-(2-oxidophenyl)-1H-imida-
zolium-2-yl)nickel (12): A solution of 0.15 g (0.70 mmol) of
2-(3-butyl-1H-imidazolium-1-yl)phenolate in 5 mL of an-
hydrous toluene was treated with 0.23 g (0.35 mmol) of bis(tri-
phenylphosphine)nickel(II) dichloride and stirred under an inert
atmosphere overnight at reflux temperature. The resulting white
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solid was filtered off, washed with THF and dried in vacuo.
Yield: 0.09 g (45%) of a yellow solid, mp: 153 °C; 1H NMR
(600 MHz, CD3OD) δ 7.67 (d, J = 2.0 Hz, 2H, H-4/4'), 7.44
(dd, J1 = 1.3 Hz, J2 = 7.5 Hz, 2H, H-11/11'), 7.36 (d, J = 2.0
Hz, 2H, H-5/5'), 7.11 (dd, J1 = 1.9 Hz, J2 = 8.2 Hz, 2H, H-8/8'),
7.08 (ddd, J1 = 1.3 Hz, J2 = 8.2 Hz, J3 = 8.9 Hz, 2H, H-9/9'),
6.72 (ddd, J1 = 1.9 Hz, J2 = 7.5 Hz, J3 = 8.9 Hz, 2H, H-10/10'),
3.68–3.63 (m, 2H, H-12/12'), 3.06–3.01 (m, 2H, H-12/12'),
2.42–2.35 (m, 2H, H-13/13'), 1.84–1.76 (m, 2H, H-13/13'),
1.27–1.21 (m, 4H, H-14/14'), 0.77 (t, J1 = 7.4 Hz, 6H, H-15/15')
ppm; 13C NMR (600 MHz, CD3OD) δ 156.8 (o, C-7/7'), 156.2
(o, C-2/2'), 128.8 (o, C-6/6'), 127.4 (+, C-9/9'), 124.2 (+, C-5/
5'), 120.9 (+, C-8/8'), 118.4 (+, C-11/11'), 118.3 (+, C-4/4'),
115.1 (+, C-10/10'), 49.8 (+, C-12/12'), 33.4 (+, C-13/13'), 19.5
(+, C-14/14'), 12.3 (+, C-15/15') ppm; IR (ATR) : 2958, 2929,
2872, 1593, 1487, 1457, 1417, 1395, 1300, 1273, 1235, 1154,
952, 840, 742, 724, 681 cm−1; ESIMS (5 V) m/z (%): 511.0
(100) [M + Na]+; HRESIMS: calcd for C26H31N4O2Ni+;
489.1800; found, 489.1800.
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